Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial

BACKGROUND: Based on promising results from a Phase I study of hepatic arterial infusion chemotherapy using a combination of miriplatin and cisplatin powder (DDP-H) for unresectable hepatocellular carcinoma (UMIN-CTR000003541), a multicenter, open-label, randomized phase II study was conducted to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimura, Kenya, Suda, Takeshi, Yokoo, Takeshi, Kamimura, Hiroteru, Kanefuji, Tsutomu, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Waguri, Nobuo, Yamagiwa, Satoshi, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425991/
https://www.ncbi.nlm.nih.gov/pubmed/28490356
http://dx.doi.org/10.1186/s12885-017-3320-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425991/
https://www.ncbi.nlm.nih.gov/pubmed/28490356
http://dx.doi.org/10.1186/s12885-017-3320-7

Ejemplares similares